Keyphrases
CCR2
100%
Pharmacokinetics
100%
CCR5 Antagonist
100%
Cenicriviroc
100%
Hepatic Impairment
57%
Bacterial Translocation
28%
Moderate to Severe
28%
Cmax
28%
Liver
14%
Blood Samples
14%
C-C Chemokine Receptor Type 5 (CCR5)
14%
Non-associated
14%
Liver Fibrosis
14%
Pharmacokinetic Changes
14%
Tolerability
14%
Once-daily
14%
N-15
14%
Nonalcoholic Steatohepatitis
14%
Hepatic Inflammation
14%
CCR5 Blockade
14%
Pharmacology, Toxicology and Pharmaceutical Science
Cenicriviroc
100%
Chemokine Receptor CCR5 Antagonist
100%
Pharmacokinetics
100%
Moderate Hepatic Impairment
42%
Biological Marker
28%
Inflammation
14%
Cytokine
14%
Nonalcoholic Fatty Liver
14%
Liver Fibrosis
14%
Tolerability
14%
Mild Hepatic Impairment
14%
Immunology and Microbiology
Pharmacokinetics
100%
CCR2
100%
CCR5
100%
Bacterial Translocation
50%
Cytokine
25%
Steatohepatitis
25%